Clinical Trials
The Doctors at Pacific Northwest Retina are dedicated to providing the best, most up-to-date treatments for our patients. To this end, our doctors have participated in several clinical trials testing new drugs for Age-Related Macular Degeneration, Diabetic Retinopathy, Retinal Vein Occlusions, Vitreomacular Traction, and Ocular Melanoma.
Listed below are the active trials in which we are participating. Some of these trials are actively enrolling patients and others have completed enrollment and the patients are in the follow-up stage of the trial. If you would like to learn more about any of these trials, please send your questions to info@pnwretina.com or by calling any of our locations:
Bellevue: 206-215-3561
Burlington: 360-205-5417
Silverdale: 360-307-0300
Now enrolling at our Bellevue, Burlington and Silverdale locations.
Enrolling Now
- A Multicenter Platform Study on the Safety, Tolerability, Bioactivity, and Pharmacokinetics of Intravitreal Therapies in Retinal Vascular and Inflammatory Diseases
- Offered at our Bellevue and Silverdale Locations
- PINNACLE - clinicaltrials.gov/study/NCT06996080
- PEAK - clinicaltrials.gov/study/NCT06990399
- A Phase 2 Multicenter, Randomized, Double-masked, Sham-controlled, Reference-arm Study to Evaluate Efficacy and Safety of ONL1204 in Patients With Geographic Atrophy (GA) Associated With Age-related Macular Degeneration (AMD)
- Offered at our Bellevue and Silverdale Locations
- GALAXY - clinicaltrials.gov/study/NCT06659445
- A Randomized, Double-Masked, Multi-Center, 3-Arm Pivotal Phase 2/3 Study to Evaluate the Efficacy and Safety of Intravitreal (IVT) EYE201/MK-8748 Compared to Aflibercept (2 mg) in Participants with Neovascular Age-Related Macular Degeneration (NVAMD)
- Offered at our Burlington location
- A Multi-Center, Randomized, DoubleMasked, Active-Comparator-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Ixoberogene soroparvovec (Ixo-vec) in Participants with Neovascular Age-Related Macular Degeneration (nAMD)
- Offered at our Silverdale Location
AQUARIUS - clinicaltrials.gov/study/NCT07482176
- A Randomized, Double-masked, Comparative Clinical Study Evaluating the Efficacy, Safety, and Immunogenicity of ABP 938 8 mg Versus EYLEA® HD (Aflibercept) Delivered via Intravitreal Injection in Participants with Neovascular Age-related Macular Degeneration
- Offered at our Bellevue and Silverdale Locations
- HYACINTH - clinicaltrials.gov/study/NCT07614776
- A Randomized, Double-masked, multicenter, 3-arm, pivotal Phase 2/3 study to evaluate the efficacy and safety of intravitreal (IVT) EYE201/MK-8748 compared to aflibercept (2mg) in participants with neovascular age-related macular degeneration (NVAMD)
- Offered at our Bellevue Location
- TORRONTES - clinicaltrials.gov/study/NCT07496567
Upcoming Trials
- A Multi-Center Registry Study to Assess the Safety and Effectiveness of Photobiomodulation (PBM) in Participants with Dry Age-Related Macular Degeneration (AMD)
- Offered at our Silverdale Location
- A Phase 3, Multicenter, Double-Masked, Randomized, 3-Arm Parallel Group Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Axitinib Implant) in Participants with Non-proliferative Diabetic Retinopathy
- Offered at our Bellevue, Burlington, and Silverdale Locations
- HELIOS 3 - clinicaltrials.gov/study/NCT07235085
- A Prospective, Two-Cohort, Multi-Center Study to Evaluate Rod Mediated Dark Adaptation (RMDA) in Subjects with Dry Age-Related Macular Degeneration (AMD)
- Offered at our Silverdale Location
